《新股表現》輝煌明天(01351.HK)暗盤高開7.3%報1.18元
根據輝立交易平台顯示,明天掛牌的輝煌明天(01351.HK)暗盤高開7.3%報1.18元,曾倒跌低見1元獲承接,現造1.4元,較上市價1.1元,高27%,成交492萬股。
輝煌明天是內地一間移動廣告公司,主要為客戶提供一站式定制廣告服務。是次來港上市共發售1.25億股,並已引入2名基石投資者合共認購3,517.4萬股;其中10%公開發售獲逾30倍超購,已啟動回撥機制佔比增至30%,認購一手中籤比率45%;股份以招股範圍(1-1.1元)上限定價,料集資淨額約8,600萬元,主要用作擴展集團中介服務、擴展營銷和設計團隊、以及提升信息技術和數據管理平台系統等。上市獨家保薦人大有融資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.